Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 06, 2016 3:24 AM ET

Healthcare Equipment and Supplies

Company Overview of TriVascular Technologies, Inc.

Executive Profile

Christopher G. Chavez

Chairman, Chief Executive Officer and President, TriVascular Technologies, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Christopher G. Chavez, also known as Chris, is a Co-Founder of TriVascular Technologies, Inc. and has been its Chairman of the Board, Chief Executive Officer and President since April 2012. Mr. Chavez has been Chairman of the Board, Chief Executive Officer and President of TV2 Holding Company since April 2012. Mr. Chavez joined St. Jude in 2005 when it acquired Advance Neuromodulation Systems. Mr. Chavez served as Chief Executive Officer and the President of Advanced ...

Corporate Headquarters

3910 Brickway Boulevard
Santa Rosa, California 95403

United States

Phone: 707-543-8800
Fax: --

Board Members Memberships

Co-Founder, Chairman, Chief Executive Officer and President
Chief Executive Officer, President and Director
Chairman, Chief Executive Officer and President


MBA 1979
Harvard Business School
Bachelor's Degree
New Mexico State University

Other Affiliations

Annual Compensation

Total Annual Compensation$450,000

Stocks Options

All Other Compensation$737
Exercisable Options$105,168
Exercisable Options Value$443,440
Unexercisable Options$229,037
Unexercisable Options Value$508,582
Total Value of Options$952,022
Total Number of Options$334,205

Total Compensation

Total Annual Cash Compensation$883,052
Total Short Term Compensation$450,000
Other Long Term Compensation$737
Total Calculated Compensation$1,756,768

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Timothy M. Ring Chairman, Chief Executive Officer and Chairman of Executive Committee
CR Bard Inc.
Michael T. Rousseau Chief Executive Officer, President, Chief Operating Officer and Director
St. Jude Medical Inc.
Michael F. Mahoney Chief Executive Officer, President and Director
Boston Scientific Corporation
John McDermott MBAChairman and Chief Executive Officer
Endologix Inc.
Simon Hubbert Chief Executive Officer and Director
Lombard Medical, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TriVascular Technologies, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at